GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (FRA:AC6) » Definitions » Other Long Term Assets

AlzeCure Pharma AB (FRA:AC6) Other Long Term Assets : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is AlzeCure Pharma AB Other Long Term Assets?

AlzeCure Pharma AB's other long-term assets for the quarter that ended in Sep. 2024 was €0.00 Mil.

AlzeCure Pharma AB's quarterly other long-term assets increased from Mar. 2024 (€-0.00 Mil) to Jun. 2024 (€-0.00 Mil) and increased from Jun. 2024 (€-0.00 Mil) to Sep. 2024 (€0.00 Mil).

AlzeCure Pharma AB's annual other long-term assets increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€3.86 Mil) but then declined from Dec. 2022 (€3.86 Mil) to Dec. 2023 (€-0.00 Mil).

AlzeCure Pharma AB Other Long Term Assets Historical Data

The historical data trend for AlzeCure Pharma AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzeCure Pharma AB Other Long Term Assets Chart

AlzeCure Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial - - - 3.86 -

AlzeCure Pharma AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AlzeCure Pharma AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

AlzeCure Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (FRA:AC6) » Definitions » Other Long Term Assets
Comparable Companies
OSTO:MOB OSTO:ERMA OSTO:VIVE XSAT:PMED XSAT:ODI XSAT:DICOT OSTO:NANEXA OSTO:NEWBRY OSTO:KLAR OSTO:RLS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ALZCUR:Sweden
Address
Halsovagen 7, Huddinge, SWE, SE 141 57
Website
https://www.alzecurepharma.se
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.

AlzeCure Pharma AB Headlines

No Headlines